# Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia

> **NCT01355276** · PHASE3 · COMPLETED · sponsor: **Eisai China Inc.** · enrollment: 400 (actual)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Cinitapride
- **DRUG:** domperidone

## Key facts

- **NCT ID:** NCT01355276
- **Lead sponsor:** Eisai China Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-10
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2011-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355276, "Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01355276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*